Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

NCT00824265 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

365

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukaemia, Lymphocytic, Chronic

Interventions

DRUG: OFC Infusion
DRUG: FC infusion

Sponsor

Novartis Pharmaceuticals